@article{JTD19962,
author = {Wen-Jing Liao and Li-Juan Song and Hong-Liang Yi and Jian Guan and Jian-Yin Zou and Hua-Jun Xu and Gang Wang and Fei Ma and Li-Bo Zhou and Yu-Qing Chen and Li-Bo Yan and Zhi-Cheng Deng and Walter T. McNicholas and Shan-Kai Yin and Nan-Shan Zhong and Xiao-Wen Zhang},
title = {Treatment choice by patients with obstructive sleep apnea: data from two centers in China},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {3},
year = {2018},
keywords = {},
abstract = {Background: Standard management has been recommended for obstructive sleep apnea (OSA) by several guidelines, but patient choice in the practical setting is unclear.
Methods: A survey nested in two prospective cohort studies of OSA (enrollment: 2001–2010) in China. The last interview was conducted between July 2014 and May 2015, using a comprehensive 10-point questionnaire administered in a face-to-face or telephone interview, and assessed (I) whether the participant had received any OSA treatment; (II) why he or she had decided for or against treatment; (III) what treatment was received; (IV) whether the participant used continuous positive airway pressure (CPAP) or OA daily; and (V) the perceived efficacy of therapy.
Results: A total of 4,097 subjects with a mean age of 45 years [37–55] responded to this survey, with a response rate of 79.4% (4,097/5,160); 2,779 subjects (67.8%) did not receive any treatment: 1,485 (53.4%) believed that their condition was not serious, despite severe OSA in 53.7% of the patients. A multivariate regression showed that the decision to receive treatment was associated with: age between 45–59 years [odds ratio (OR) 0.805, 95% CI: 0.691–0.936; P},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/19962}
}